Health Economics Review

Fig. 3 | Health Economics Review

Fig. 3

From: Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands

Fig. 3

ISSN: 2191-1991

Contact us

Submission enquiries: kenneth.sayson@springernature.com
General enquiries: info@biomedcentral.com